Gene profiling and kinase screening in asbestos-exposed epithelial cells and lungs

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 3 II, 2003, Pages

  Ramos Nino, Maria E ^a   Heintz, Nicolas ^a   Scapoli, Luca ^a   Martinelli, Marcella ^a   Land, Susan ^a   Nowak, Norma ^a   Haegens, Astrid ^a   Manning, Brian ^a   Manning, Nicole ^a   MacPherson, Maximilian ^a   Stern, Maria ^a   Mossman, Brooke ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; PHOSPHOTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; ENZYME ANALYSIS; GENE EXPRESSION; GENE IDENTIFICATION; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; UNINDEXED SEQUENCE;

ANIMALIA;

EID: 0042328222     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Selman, M., T. King, and A. Pardo. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136-151.
2. Crystal, R., P. Bitterman, B. Mossman, M. Schwarz, D. Sheppard, L. Almasy, H. Chapman, S. Friedman, T. King, L. Leinwand, L. Liotta, G. Martin, D. Schwartz, G. Schultz, C. Wagner, and R. Musson. 2002. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am. J. Respir. Crit. Care Med. 166:236-246.
3. Pardo, A., and M. Selman. 2002. Molecular mechanisms of pulmonary fibrosis. Front. Biosci. 7:d1743-d1761.
4. Smith, R., R. Strieter, S. Phan, and S. Kunkel. 1996. C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge. Am. J. Respir. Cell Mol. Biol. 15:693-702.
5. Hagimoto, N., K. Kuwano, Y. Nomoto, R. Kunitake, and N. Hara. 1997. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16:91-101.
6. Mossman, B., and A. Churg. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157:1666-1680.
7. Cottin, V. 2002. Treatment of pulmonary fibrosis. Presse Med. 31:1613-1623.
8. Selman, M., and A. Pardo. 2002. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 3:3
9. Das, K., and C. White. 1997. Activation of NF-kB by antineoplastic agents. J. Biol. Chem. 272:14914-4920.
10. Li, Q., P. W. Park, C. L. Wilson, and W. C. Parks. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635-646.
11. Sternlicht, M. D., and Z. Werb. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516.
12. Malkinson, A., L. Dwyer-Nield, P. Rice, and D. Dinsdale. 1997. Mouse lung epithelial cell lines - tools for the study of differentiation and the neoplastic phenotype. Toxicology 123:53-100.
13. Manning, C., A. Cummins, M. Jung, I. Berlanger, C. Timblin, C. Palmer, D. Taatjes, D. Hemenway, P. Vacek, and B. Mossman. 2002. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression. Cancer Res. 62:4169-4175.
14. Buder-Hoffmann, S., C. Palmer, P. Vacek, D. Taatjes, and B. Mossman. 2001. Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 24:405-413.
15. Allen, J. T., R. A. Knight, C. A. Bloor, and M. A. Spiteri. 1999. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am. J. Respir. Cell Mol. Biol. 21:693-700.
16. Allen, J. T., C. A. Bloor, R. A. Knight, and M. A. Spiteri. 1998. Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Am. J. Respir. Cell Mol. Biol. 19:250-258.
17. Allen, J. T., C. A. Bloor, R. K. Kedia, R. A. Knight, and M. A. Spiteri. 2000. Expression of growth hormone-releasing factor, growth hormone, insulin-like growth factor-1 and its binding proteins in human lung. Neuropeptides 34:98-107.
18. Vassalli, J. D., A. P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
19. Bini, A., D. Wu. J. Schnuer, and B. J. Kudryk. 1999. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. Biochemistry 38:13928-13936.
20. Kaminski, N., J. D. Allard, J. F. Pittet, F. Zuo, M. J. Griffiths, D. Morris, X. Huang, D. Sheppard, and R. A. Heller. 2000. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc. Natl. Acad. Sci. USA 97:1778-1783.
21. Gross, T. J., S. M. Cobb, D. C. Gruenert, and M. W. Peterson. 1993. Asbestos exposure increases human bronchial epithelial cell fibrinolytic activity. Am. J. Physiol. 264:L276-L283.
22. Perkins, R., V. Broaddus, S. Shetty, S. Hamilton, and S. Idell. 1999. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Am. J. Respir. Cell Mol. Biol. 21:637-646.
23. Barchowsky, A., R. R. Roussel, R. J. Krieser, B. T. Mossman, and M. D. Treadwell. 1998. Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos. Toxicol. Appl. Pharmacol. 152:388-396.
24. Lardot, C. G., F. A. Huaux, F. R. Broeckaert, P. J. Declerck, M. Delos, B. Fubini, and D. F. Lison. 1998. Role of urokinase in the fibrogenic response of the lung to mineral particles. Am. J. Respir. Crit. Care Med. 157:617-628.
25. Kamp, D., V. Panduri, S. Weitzman, and N. Chandel. 2002. Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals. Mol. Cell. Biochem. 234-235:153-160.
26. Broaddus, V., L. Yang, L. Scavo, J. Ernst, and A. Boylan. 1996. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J. Clin. Invest. 98:2050-2059.
27. Mossman, B. T. 1990. In vitro studies on the biologic effects of fibers: correlation with in vivo bioassays. Environ. Health Perspect. 88:319-322.
28. Reddy, S., and B. Mossman. 2002. Role and regulation of activator protein-1 (AP-1) in toxicant-induced responses of the lung. Am. J. Physiol. (Lung Cell Mol. Physiol.) 283:L1161-L1178.
29. Teder, P., R. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, P. Henson, and P. Noble. 2002. Resolution of lung inflammation by CD44. Science 296:155-158.
30. Zanella, C., J. Posada, T. Tritton, and B. Mossman. 1996. Asbestos causes stimulation of the ERK-1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res. 56:5334-5338.
31. 2. Am. J. Physiol. (Lung Cell Mol. Physiol.) 273:L1029-L1035.
32. Pache, J., Y. Janssen, E. Walsh, T. Quinlan, C. Zanella, R. Low, D. Taatjes, and B. Mossman. 1998. Increased epidermal growth factor-receptor (EGF-R) protein in a human mesothelial cell line in response to long asbestos fibers. Am. J. Pathol. 152:333-340.
33. Zanella, C., C. Timblin, A. Cummins, M. Jung, J. Goldberg, R. Raabe, T. Tritton, and B. T. Mossman. 1999. Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos expression and apoptosis. Am. J. Physiol. (Lung Cell Mol. Physiol.) 277:L684-L693.
34. Robledo, R., S. Buder-Hoffmann, A. Cummins, E. Walsh, D. Taatjes, and B. Mossman. 2000. Increased phosphorylated ERK immunoreactivity associated with proliferative and morphologic lung alterations following chrysotile asbestos inhalation in mice. Am. J. Pathol. 156:1307-1316.
35. Zanella, C., C. Timblin, A. Cummins, M. Jung, J. Goldberg, R. Raabe, T. Tritton, and B. Mossman. 1999. Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos expression and apoptosis. Am. J. Physiol. (Lung Cell Mol. Physiol.) 277:L684-L693.
36. Tuomala, M., M. R. Hirvonen, and K. M. Savolainen. 1993. Changes in free intracellular calcium and production of reactive oxygen metabolites in human leukocytes by soluble and particulate stimuli. Toxicology 80:71-82.
37. Ruotsalainen, M., J. Naarala, and K. M. Savolainen. 1995. Mineral fiber-induced leukocyte activation: the role of intra- and extracellular calcium. Toxicol. Lett. 78:195-205.
38. Fung, H., T. R. Quinlan, Y. M. Janssen, C. R. Timblin, J. P. Marsh, N. H. Heintz, D. J. Taatjes, P. Vacek, S. Jaken, and B. T. Mossman. 1997. Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells. Cancer Res. 57:3101-3105.
39. Perderiset, M., J. P. Marsh, and B. T. Mossman. 1991. Activation of protein kinase C by crocidolite asbestos in hamster tracheal epithelial cells. Carcinogenesis 12:1499-1502.
40. Lounsbury, K. M., M. Stern, D. Taatjes, S. Jaken, and B. T. Mossman. 2002. Increased localization and substrate activation of protein kinase C delta in lung epithelial cells following exposure to asbestos. Am. J. Pathol. 160:1991-2000.
41. Hardy, J., and A. Aust. 1995. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16:319-325.
42. Adamson, I., and D. Bowden. 1987. Response of mouse lung to crocidolite asbestos. 2. Pulmonary fibrosis after long fibres. J. Pathol. 152:109-117.
43. Sime, P. J., R. A. Marr, D. Gauldie, Z. Xing, B. R. Hewlett, F. L. Graham, and J. Gauldie. 1998. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am. J. Pathol. 153:825-832.
44. Brass, D., G. Hoyle, H. Poovey, J. Liu, and A. Brody. 1999. Reduced tumor necrosis factor-alpha and transforming growth factor-beta1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure. Am. J. Pathol. 154:853-862.
45. Allen, J. T., and M. A. Spiteri. 2002. Growth factors in idiopathic pulmonary fibrosis: relative roles. Respir. Res. 3:13-21.
46. Idell, S., A. P. Mazar, P. Bitterman. S. Mohla, and A. L. Harabin. 2001. Fibrin turnover in lung inflammation and neoplasia. Am. J. Respir. Crit. Care Med. 163:578-584.
47. Eitzman, D. T., R. D. McCoy, X. Zheng, W. P. Fay, T. Shen, D. Ginsburg, and R. H. Simon. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97:232-237.
48. Barchowsky, A., R. Roussel, R. Krieser, B. Mossman, and M. Treadwell. 1998. Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos. Toxicol. Appl. Pharmacol. 152:388-396.